Latest Half Year Financial Results News

New Zealand King Salmon (NZX: NZK) has sharply upgraded its FY26 earnings guidance, citing better-than-expected summer fish growth and lower mortality. The company now expects pro-forma EBITDA between $19 million and $27 million, up from $9 million to $15 million previously.

Vysarn Limited's joint venture with Kariyarra Aboriginal Corporation has been shortlisted by Water Corporation to submit a formal proposal for supplying bulk water to Port Hedland, progressing key regulatory approvals for the Kariyarra Water Scheme.

DGL Group Limited has agreed to sell two chlor-alkali manufacturing plants for $2.5 million, well below their carrying value, reflecting a $5.3 million impairment charge. The sale aligns with the company’s strategic focus on core operations and is not expected to materially affect ongoing activities.

Spenda Limited (ASX:SPX) has announced a 1-for-20 security consolidation affecting its ordinary shares and multiple option classes, with key dates scheduled throughout May 2026.

Schaffer Corporation Limited (ASX:SFC) has closed its prior on-market share buy-back program that ended on 30 June 2025 and announced the commencement of a new buy-back, with further details pending.

Duratec Limited has delivered its strongest half-year performance to date, reporting record revenue and gross profit across its diversified engineering and construction services. The company’s investor briefing highlighted robust order books, strategic growth in Defence and Energy sectors, and expansion into new regional markets.

KMD Brands has requested a voluntary suspension of its shares on both the NZX and ASX as it finalises a capital raise, refinancing, and its half-year financial results. The suspension aims to maintain market order while key details remain under negotiation.

KMD Brands Limited has announced plans for a capital raise via placement and AREO, coinciding with its upcoming half-year financial results. The company has requested a trading halt as it finalises the terms.

Synlait confirms the imminent sale of its North Island assets to Abbott for NZ$307 million, aiming to reset its balance sheet amid a challenging half-year result. The company unveils a recovery roadmap focused on stabilising and scaling its core operations.

CLINUVEL Pharmaceuticals reports record first-half profits and confirms CEO Philippe Wolgen’s leadership through a pivotal growth phase, prioritising its vitiligo program and Nasdaq ambitions.

MCS Services Limited reported a 32% revenue decline for the half-year ending December 2025, alongside improved EBITDA and no significant impairments. The company is moving forward with a proposed sale of its Highways Traffic business, though an auditor’s going concern warning casts a shadow over its near-term outlook.

The Star Entertainment Group reports a $110 million statutory loss for H1 FY26 as it undertakes major operational restructuring and seeks refinancing amid challenging market conditions.